NCT02629263
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Clinical Nutrition and Risk Factor Modification Centre Toronto, Ontario, Canada
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
155 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02920918
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
- Locations
-
- Virginia Commonwealth University Richmond, Virginia, United States
NCT04141111
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- APDP Lisbon, Portugal
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Hanoi, Vietnam
NCT01966978
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
Completed
Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics
NCT04120259
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Ziauddin University Karachi, Sindh, Pakistan
Completed
Mobile Health Application for Diabetes
NCT04132089
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
Completed
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
NCT03191396
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Burgas, Bulgaria
- Novo Nordisk Investigational Site Dupnitsa, Bulgaria
- Novo Nordisk Investigational Site Lukovit, Bulgaria
- Novo Nordisk Investigational Site Madan, Bulgaria
NCT02648204
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Tuscumbia, Alabama, United States
- Novo Nordisk Investigational Site Chandler, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
NCT02806973
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mount Royal, Quebec, Canada